Quantcast

Latest ImmunoCellular Therapeutics Ltd. Stories

2015-03-19 08:26:39

LOS ANGELES and MAASTRICHT, The Netherlands, March 19, 2015 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd.

2015-03-09 16:33:58

ICT-107 Poised to Begin Phase 3 Registration Trial in Second Half of 2015; Business Update Conference Call to be Held on March 12, 2015 LOS ANGELES, March 9, 2015 /PRNewswire/ -- ImmunoCellular

2015-03-03 08:34:21

LOS ANGELES, March 3, 2015 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd.

2015-02-18 16:26:54

LOS ANGELES, Feb. 18, 2015 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today announced the appointment of Steven J.

2015-02-12 08:35:24

LOS ANGELES, Feb. 12, 2015 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd.

2015-01-28 08:30:29

LOS ANGELES, Jan. 28, 2015 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd.

2014-12-17 08:27:54

LOS ANGELES, Dec. 17, 2014 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd.

2014-12-01 08:29:12

LOS ANGELES, Dec. 1, 2014 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd.

2014-11-14 08:27:59

Continued Positive Trends in Overall Survival and Progression-Free Survival; LOS ANGELES, Nov. 14, 2014 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd.


Word of the Day
deuteragonist
  • A person in a secondary role, specifically the second most important character (after the protagonist).
The word 'deuteragonist' comes from a Greek word meaning 'an actor of second-class parts'.
Related